Assignee
ELPISCIENCE SUZHOU BIOPHARMA LTD
CN·1 granted patent·7 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
8 records- 0152US2026008847A1Anti-lilrb2 antibodies and uses thereofELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2023·Application pending·0 cites
- 0248US2025313625A1Novel anti-lag3 antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 0348US2025270315A1Novel anti-sirpa antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 0448US2024336686A1Novel multi-specific moleculesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2022·Application pending·0 cites
- 0542US2023416394A1Novel conjugate molecules targeting cd39 and tgfbetaELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 0640US2024270839A1Novel anti-claudin18 antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2021·Application pending·0 cites
- 0738US2021347908A1Novel anti-sirpa antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2020·Application pending·0 cites
- 0837US12312410B2Anti-CD39 antibodiesELPISCIENCE SUZHOU BIOPHARMA LTD·Filed 2020·Granted May 27, 2025·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when ELPISCIENCE SUZHOU BIOPHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →